BBH.L

BB Healthcare Trust (Red)
Bellevue Healthcare - Transaction in Own Shares
23rd December 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 0046R
Bellevue Healthcare Trust PLC
23 December 2024
 

Bellevue Healthcare Trust plc

 


Transaction in own shares

 


Bellevue Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc.



Date of purchase:

20 December 2024

Number of ordinary shares purchased:

875,243

Trading venue

LSE

Average price paid per share:

135.72p



The Company intends to hold the purchased shares in treasury.



Following the above transaction, the Company holds 54,963,315 of its ordinary shares in treasury and has 260,188,994 ordinary shares in issue (excluding treasury shares).



The Company's LEI is: 213800HQ3J3H9YF2UI82




Enquiries:

 

 Bellevue Asset Management (UK) Ltd.

 

 Mark Ghahramani


 Telephone: +44 (0) 203 326 2981




 J.P. Morgan Cazenove

 

 James Bouverat (Sales)


 Telephone: +44 (0) 207 134 2224




NSM Funds (UK) Limited

 

Brian Smith, Ciara McKillop


Telephone: +44 (0)20 3697 5770


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFERFELIFIS]]>
TwitterFacebookLinkedIn